论文----中国-新西兰生物医药与健康联合实验室

科研进展论文专利奖项科研项目

论文

Discovery of highly potent and efficient CBP/p300 degraders with strong in vivo antitumor activity

Jiankang Hu,Hongrui Xu,Tianbang Wu,Cheng Zhang,Hui Shen,Ruibo Dong,Qingqing Hu,Qiuping Xiang,Shuang Chai,Guolong Luo,Xiaoshan Chen,Yumin Huang,Xiaofan Zhao,Chao Peng,Xishan Wu,Bin Lin,Yan Zhang,Yong Xu.
Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma

Linfu Zhou,Yao Li,Diwei Zheng,Yongfang Zheng,Yuanbin Cui,Le Qin,Zhaoyang Tang,Dongdong Peng,Qiting Wu,Youguo Long,Yao Yao,Nathalie Wong,James Lau,Peng Li.
Targeted mutagenesis in mice via an engineered AsCas12f1 system

Peng Fan,Hejun Wang,Feiyu Zhao1,Tao Zhang,Jinze Li,Xiaodi Sun,Yongduo Yu,Haoyang Xiong,Liangxue Lai,Tingting Sui.
Programmable RNA 5-methylcytosine (m5C) modification of cellular RNAs by dCasRx conjugated methyltransferase and demethylase

Tao Zhang,Feiyu Zhao,Jinze Li,Xiaodi Sun,Xiyun Zhang,Hejun Wang,Peng Fan,Liangxue Lai,Zhanjun Li,Tingting Sui.
An optimized culture system for efficient derivation of porcine expanded potential stem cells from preimplantation embryos and by reprogramming somatic cells

Degong Ruan,Yiyi Xuan,Timothy Theodore Ka Ki Tam,ZhuoXuan Li,Xiao Wang,Shao Xu,Doris Herrmann,Heiner Niemann,Liangxue Lai,Xuefei Gao,Monika Nowak-Imialek,Pentao Liu.

1